|
Eiko Lifesciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
74.63 Cr.
|
P/BV
|
1.32
|
Book Value (Rs.)
|
41.36
|
|
52 Week High/Low (Rs.)
|
75/42
|
FV/ML
|
10/1
|
P/E(X)
|
35.46
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
1.53
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| PER SHARE RATIOS | | | | |
| | | | | |
| Basic EPS (Rs.) | 1.62 | -4.99 | -1.16 | 0.63 |
| Diluted EPS (Rs.) | 1.62 | -4.99 | -1.16 | 0.63 |
| Cash EPS (Rs.) | 2.12 | -8.97 | -1.61 | 0.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 41.26 | 2.91 | 12.58 | 15.14 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 41.26 | 2.91 | 12.58 | 15.14 |
| Revenue From Operations / Share (Rs.) | 27.37 | 28.25 | 11.11 | 6.12 |
| PBDIT / Share (Rs.) | 2.52 | -11.54 | -1.71 | 1.08 |
| PBIT / Share (Rs.) | 1.99 | -12.04 | -2.16 | 0.86 |
| PBT / Share (Rs.) | 2.12 | -12.92 | -2.61 | 0.64 |
| Net Profit / Share (Rs.) | 1.58 | -9.48 | -2.05 | 0.52 |
| NP After MI And SOA / Share (Rs.) | 1.53 | -4.99 | -1.16 | 0.51 |
| | | | | |
| PROFITABILITY RATIOS | | | | |
| | | | | |
| PBDIT Margin (%) | 9.22 | -40.83 | -15.37 | 17.63 |
| PBIT Margin (%) | 7.27 | -42.62 | -19.40 | 14.15 |
| PBT Margin (%) | 7.75 | -45.72 | -23.50 | 10.51 |
| Net Profit Margin (%) | 5.77 | -33.54 | -18.47 | 8.58 |
| NP After MI And SOA Margin (%) | 5.59 | -17.66 | -10.47 | 8.39 |
| Return on Networth / Equity (%) | 3.70 | -64.71 | -9.02 | 3.52 |
| Return on Capital Employeed (%) | 4.57 | -168.96 | -15.76 | 5.25 |
| Return On Assets (%) | 3.18 | -15.81 | -4.77 | 1.79 |
| Long Term Debt / Equity (X) | 0.03 | 0.54 | 0.08 | 0.08 |
| Total Debt / Equity (X) | 0.04 | 0.54 | 0.27 | 0.31 |
| Asset Turnover Ratio (%) | 0.00 | 0.05 | 0.04 | 0.00 |
| | | | | |
| LIQUIDITY RATIOS | | | | |
| | | | | |
| Current Ratio (X) | 5.25 | 0.53 | 1.02 | 1.28 |
| Quick Ratio (X) | 4.33 | 0.19 | 0.45 | 0.61 |
| | | | | |
| COVERAGE RATIOS | | | | |
| | | | | |
| Interest Coverage Ratio (%) | 21.90 | -13.16 | -3.75 | 4.86 |
| Interest Coverage Ratio (Post Tax) (%) | 12.56 | -9.81 | -3.51 | 3.36 |
| | | | | |
| VALUATION RATIOS | | | | |
| | | | | |
| Enterprise Value (Cr.) | 63.22 | 3.63 | 22.93 | 19.88 |
| EV / Net Operating Revenue (X) | 1.68 | 0.33 | 5.40 | 8.51 |
| EV / EBITDA (X) | 18.19 | -0.82 | -35.12 | 48.23 |
| MarketCap / Net Operating Revenue (X) | 1.91 | 0.35 | 5.13 | 8.01 |
| Price / BV (X) | 1.27 | 1.32 | 4.43 | 3.37 |
| Price / Net Operating Revenue (X) | 1.91 | 0.35 | 5.13 | 8.01 |
| EarningsYield | 0.02 | -0.49 | -0.02 | 0.01 |
